← Back to Search

Experimental - Error Augmented feedback (Restricted area) for Stroke Rehabilitation

N/A

Waitlist Available

Led By Mindy F Levin, PhD

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up before treatment baseline, week 3, week 6, week 9 and week 13

Awards & highlights

Study Summary

This trial is testing whether a new type of intensive training, focused on improving the individual's ability to control their movement, is more effective than the current standard of care for post-stroke patients.

Eligible Conditions

Stroke Rehabilitation
Weakness of the Upper Extremity
Stroke
Muscle Spasms

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ before treatment baseline, week 3, week 6, week 9 and week 13

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~before treatment baseline, week 3, week 6, week 9 and week 13

This trial's timeline: 3 weeks for screening, Varies for treatment, and before treatment baseline, week 3, week 6, week 9 and week 13 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in elbow spatial threshold (ST) angle and the range of active elbow extension

Secondary outcome measures

Arm workspace area, movement quality variables, clinical measures of UL functional level

Change in Fugl-Meyer Assessment Upper extremity (FMA)

Change in accuracy relative to target during reach task

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental - Error Augmented feedback (Restricted area)Experimental Treatment5 Interventions

Error augmented feedback. Random targets always INSIDE of workspace area.

Group II: Control - General feedback (Full area)Active Control5 Interventions

General feedback about task success. Random target INSIDE or OUTSIDE of workspace area.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Magnetic resonance imaging (MRI)

2019

Completed Phase 4

~1080

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor

394 Previous Clinical Trials

998,327 Total Patients Enrolled

Mindy F Levin, PhDPrincipal InvestigatorMcGill University

1 Previous Clinical Trials

50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical research currently seeking out new participants?

"According to clinicaltrials.gov, the patient recruitment phase of this trial has been completed and closed since May 5th 2020. This trial was first listed on September 1st 2020; however, 1115 other trials are presently enrolling individuals at this time."

Answered by AI

Am I eligible to join this research protocol?

"This clinical trial seeks 54 individuals afflicted with cerebrovascular stroke between the ages of 40 and 75. To qualify, applicants must exhibit arm paresis (Chedoke-McMaster Arm Scale from 2-6 out of 7), be in a sub-acute stage, not currently undergoing treatment, and show some voluntary elbow movement (30° per direction)."

Answered by AI

Does the age qualification for this research encompass individuals above 75 years old?

"The parameters for this medical trial require participants to be between 40 and 75 years old. In contrast, there are 62 studies accepting minors and 1058 trials open to seniors."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Error Augmentation Motor Learning Training Approach in Stroke Patients

2020. "Error Augmentation Motor Learning Training Approach in Stroke Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04378946.